Inhibitors targeting RIPK1/RIPK3 : old and new drugs
(2020) Sofie Martens (UGent), Sam Hofmans, Wim Declercq (UGent), Koen Augustyns, Peter Vandenabeele (UGent)
Necroptotic proteins in diseases : targeting RIP kinases in inflammatory disorders and exploring the role of MLKL in melanoma development
(2019) Sofie Martens (UGent)
Tozasertib analogues as inhibitors of necroptotic cell death
(2018) Sam Hofmans, Lars Devisscher, Sofie Martens (UGent), Dries Van Rompaey, Kenneth Goossens, Tatyana Divert (UGent), Wim Nerinckx (UGent), Nozomi Takahashi (UGent), Hans De Winter, Pieter Van der Veken, Vera Goossens (UGent), Peter Vandenabeele (UGent), Koen Augustyns
Personal data from this phone book may only be used for communication with individuals in the context of the mission of Ghent University.